Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
REVB Revelation Biosciences Inc
- Stocks
- Healthcare
- NASDAQ: REVB
Price (delayed)
$3.05
Market cap
$2.94M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$67.23
Enterprise value
-$765,033
Highlights
The EPS has surged by 85% year-on-year and by 23% since the previous quarter
The quick ratio is up by 22% year-on-year
The net income has shrunk by 61% YoY but it is up by 4.2% QoQ
REVB's equity has dropped by 70% year-on-year and by 39% since the previous quarter
Key stats
What are the main financial stats of REVB
Market
Valuations
Earnings
Shares outstanding
963,796
Market cap
$2.94M
Enterprise value
-$765,033
Price to earnings (P/E)
N/A
Price to book (P/B)
0.96
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$8.17M
Net income
-$14.41M
EBIT
-$14.41M
EBITDA
-$14.38M
Free cash flow
-$18.28M
Per share
Balance sheet
Liquidity
EPS
-$67.23
EPS diluted
-$67.23
Free cash flow per share
-$18.82
Book value per share
$3.18
Revenue per share
$0
TBVPS
$4.09
Total assets
$3.97M
Total liabilities
$1.09M
Debt
$0
Equity
$2.88M
Working capital
$2.84M
Debt to equity
0
Current ratio
3.61
Quick ratio
3.4
Net debt/EBITDA
0.26
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-194.7%
Return on equity
-505.4%
Return on invested capital
N/A
Return on capital employed
-500.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
REVB stock price
How has the Revelation Biosciences stock price performed over time
Intraday
0.66%
1 week
-4.03%
1 month
1.67%
1 year
-89.75%
YTD
-58.67%
QTD
15.97%
Financial performance
How have Revelation Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$8.17M
Net income
-$14.41M
Gross margin
N/A
Net margin
N/A
The net income has shrunk by 61% YoY but it is up by 4.2% QoQ
REVB's operating income is up by 9% YoY but it is down by 2.4% from the previous quarter
Price vs fundamentals
How does REVB's price correlate with its fundamentals
Growth
What is Revelation Biosciences's growth rate over time
Valuation
What is Revelation Biosciences stock price valuation
P/E
N/A
P/B
0.96
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 85% year-on-year and by 23% since the previous quarter
REVB's equity has dropped by 70% year-on-year and by 39% since the previous quarter
The price to book (P/B) is 13% lower than the last 4 quarters average of 1.1
Efficiency
How efficient is Revelation Biosciences business performance
REVB's return on equity has dropped by 51% since the previous quarter
The company's return on assets fell by 31% QoQ
Dividends
What is REVB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for REVB.
Financial health
How did Revelation Biosciences financials performed over time
Revelation Biosciences's total liabilities has plunged by 79% YoY and by 43% from the previous quarter
The company's total assets has shrunk by 73% YoY and by 40% QoQ
The debt is 100% less than the equity
REVB's equity has dropped by 70% year-on-year and by 39% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.